Synapticure is a clinical research site located in Chicago, Illinois, United States 60613.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Synapticure has participated in 2 clinical trials.
Therapeutic areas: ALS, Amyotrophic Lateral Sclerosis, PALS.
Sponsors: Clene Nanomedicine, Spinogenix.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Synapticure has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Synapticure has 2 clinical trials on record. Their work covers ALS, Amyotrophic Lateral Sclerosis, PALS.
Synapticure has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.